Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
ETF IssuersRISE ETF253290
253290

RISE Healthcare Fixed Income Balanced ETF

The 253290 Exchange Traded Fund (ETF) is provided by RISE ETF. It is built to track an index: FnGuide Inc Healthcare Balanced Index. The 253290 ETF provides physical exposure, so by buying it you actually own parts of all the 49 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

₩11,355
+₩90 (+0.80%) today
12:00 AM 07/30/26 Closed
1D price range
₩11,250₩11,440
52W price range
₩11,336.8₩13,545.48
YTD Perf.
-10.70%
YTD Flows
Annualized volatility
Fund AuM
€12M
Share class AuM
€12M
TTM Yield
Tracking Error
Tracking Difference
ISIN
KR7253290001
TER
0.35%
Inception date
9/23/2016
Issuer
Replication method
Dividend policy
Compare similar ETFs

No content available for this fund

API
PerformanceDec 30, 2025 - Jul 29, 2026
-10%-5%0%5%JANMARMAYJUL
Flows
Join for free to unlock

No content available for this fund

Latest 253290 news

No content available for this fund

FAQ about 253290

253290 is a Passive ETF. This ETF provides exposure to South Korean Health Care Investment Grade Government Equities and Bonds.
253290 tracks the FnGuide Inc Healthcare Balanced Index - KRW, through a full replication replication method.
253290 carries a total expense ratio (TER) of 0.35%, indicating the annual cost for holding the fund.
253290 was introduced to the market on September 23, 2016. It trades on Democratic People's Republic of Korea, among other exchanges
RISE Healthcare Fixed Income Balanced ETF, 253290, is provided by RISE ETF. Learn more about RISE ETF here.
253290 oversees €12M in assets as of July 29, 2026.
253290 follows a distributing dividend policy, meaning it pays out income to investors. As of July 29, 2026, its 12-month trailing yield was 1.32%.
As of June 30, 2026, 253290 holds 49 positions in its portfolio, with 99.94% of assets concentrated in its top 15 holdings.
As of June 30, 2026, 253290 top three holdings include KR103503GG37, KR103501GFC3 and KR103501GF63.
The base currency of 253290 is KRW.
Data as of 06/30/26
KR103503GG37
45.64%
KR103501GFC3
27.21%
KR103501GF63
27.08%
KR7114100001
0.00%
Celltrion, Inc.
0.00%
Alteogen, Inc.
0.00%
SAMSUNG BIOLOGICS Co., Ltd.
0.00%
HLB Co., Ltd.
0.00%
SK Biopharmaceuticals Co., Ltd.
0.00%
LigaChem Biosciences, Inc.
0.00%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight